Hepatitis E vaccine: Current status and future prospects

Future Virology

Volumn 4, Issue 2, 2009, Pages 143-154

  Amini Bavil Olyaee, Samad ^a   Trautwein, Christian ^a   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Acute hepatitis; Antigenicity; Chronic liver disease; Clinical trial; Hepatitis E; HEV; Pregnancy; Prevention; Vaccination; Vaccine

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA VACCINE; HEPATITIS E VACCINE; PLACEBO;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; CLINICAL TRIAL; DRUG EFFICACY; HEPATITIS E; HEPATITIS E VIRUS; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INJECTION SITE PAIN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS TRANSMISSION;

MIRIDAE; SPODOPTERA;

EID: 70349399152     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460794.4.2.143     Document Type: Review

References (75)

1. Moucari R, Bernuau J, Nicand E et al.: Acute hepatitis E with severe jaundice: report of three cases. Eur. J. Gastroenterol. Hepatol. 19, 1012-1015 (2007).
2. Piper-Jenks N, Horowitz HW, Schwartz E: Risk of hepatitis E infection to travelers. J. Travel Med. 7, 194-199 (2000).
3. Schwartz E, Jenks NP, Van Damme P, Galun E: Hepatitis E virus infection in travelers. Clin. Infect. Dis. 29, 1312-1314 (1999).
4. Bader TF, Krawczynski K, Polish LB, Favorov MO: Hepatitis E in a U.S. traveler to Mexico. N. Engl. J. Med. 325, 1659 (1991).
5. Krawczynski K: Hepatitis E vaccine: ready for prime time? N. Engl. J. Med. 356, 949-951 (2007).
6. Purcell RH, Emerson SU: Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 48, 494-503 (2008).
7. Panda SK, Thakral D, Rehman S: Hepatitis E virus. Rev. Med. Virol. 17, 151-180 (2007).
8. Mushahwar IK: Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J. Med. Virol. 80, 646-658 (2008).
9. Ayoola EA, Want MA, Gadour MOEH et al.: Hepatitis E virus infection in haemodialysis patients: a case-control study in Saudi Arabia. J. Med. Virol. 66, 329-334 (2002).
10. Khuroo MS, Dar MY: Hepatitis E: evidence for person-to-person transmission and inability of low close immune serum globulin from an Indian source to prevent it. Indian J. Gastroenterol. 11, 113-116 (1992).
11. Boxall E, Herborn A, Kochethu G et al.: Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus. Med. 16, 79-83 (2006).
12. Matsubayashi K, Kang JH, Sakata H et al.: A case of transfusion-transmitted hepatitis E caused by blood from donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 48, 1368-1375 (2008).
13. Singh S, Mohanty A, Joshi YK, Deka D, Mohanty S, Panda SK: Mother-to-child transmission of hepatitis E virus infection. Indian J. Pediatr. 70, 37-39 (2003).
14. Pavio N, Renou C, Di Liberto G, Boutrouille A, Eloit M: Hepatitis E: a curious zoonosis. Front. Biosci. 13, 7172-7183 (2008).
15. Bouwknegt M, Frankena K, Rutjes SA et al.: Estimation of hepatitis E virus transmission among pigs due to contact-exposure. Vet. Res. 39, 40 (2008).
16. Renou C, Moreau X, Pariente A et al.: A national survey of acute hepatitis E in France. Aliment. Pharmacol. Ther. 27, 1086-1093 (2008).
17. Lu L, Li C, Hagedorn CH: Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16, 5-36 (2006).
18. Okamoto H: Genetic variability and evolution of hepatitis E virus. Virus Res. 127, 216-228 (2007).
19. Jameel. S: Molecular biology and pathogenesis of hepatitis E virus. Expert Rev. Mol. Med. 1-16 (1999).
20. Bhagat S, Wadhawan M, Sud R, Arora A: Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas 36, 424-427 (2008).
21. Navaneethan U, Al Mohajer M, Shata MT: Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 28(9), 1190-1199 (2008).
22. Kar P, Jilani N, Husain SA et al.: Does hepatitis E viral-load and genotypes influence the final outcome of acute liver failure during pregnancy. Am. J. Gastroenterol. 103(10), 2495-2501 (2008).
23. Kumar A, Beniwal M, Kar P, Sharma JB, Murthy NS: Hepatitis E in pregnancy. Int. J. Gynaecol. Obstet. 85, 240-244 (2004).
24. Boccia D, Guthmann JP, Klovstad H et al.: High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin. Infect. Dis. 42, 1679-1684 (2006).
25. Oncu S, Oncu S, Okyay P, Ertug S, Sakarya S: Prevalence and risk factors for HEV infection in pregnant women. Med. Sci. Monit. 12, CR36-CR39 (2006).
26. Patra S, Kumar A, Trivedi SS, Puri M, Sarin SK: Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann. Intern. Med. 147, 28-33 (2007).
27. Jilani N, Das BC, Husain SA et al.: Hepatitis E virus infection and fulminant hepatitis failure during pregnancy. J. Gastroenterol. Hepatol. 22, 676-682 (2007).
28. Guthmann JP, Klovstad H, Boccia D et al.: A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin. Infect. Dis. 42, 1685-1691 (2006).
29. Stoszek SK, Abdel-Hamid M, Saleh DA et al.: High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans. R. Soc. Trop. Med. Hyg. 100, 95-101 (2006).
30. Rasheeda CA, Navaneethan U, Jayanthi V: Liver disease in pregnancy and its influence on maternal and fetal mortality: a prospective study from Chennai, Southern India. Eur. J. Gastroenterol. Hepatol. 20, 362-364 (2008).
31. Kamar N, Mansuy JM, Esposito L et al.: Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am. J. Kidney. Dis. 45, 193-196 (2005).
32. Kamar N, Mansuy JM, Cointault O et al.: Hepatitis E virus-related cirrhosis in kidney-and kidney-pacreas-transplant recipients. Am. J. Translant. 8, 1744-1748 (2008).
33. Kamar N, Selves J, Mansuy JM et al.: Hepatitis E virus and chronic hepatitis in organ transplant recipients. N. Engl. J. Med. 358, 811-817 (2008).
34. Haagsma EB, van den Berg AP, Porte RJ et al.: Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl. 14, 547-553 (2008).
35. Aggarwal R: Hepatitis E: does it cause chronic hepatitis? Hepatology 48, 1328-1330 (2008).
36. Tacke F, Trautwein C: Efficient recombinant hepatitis E virus vaccine: mission accomplished? Hepatology 46, 941-943 (2007).
37. Ghorbani G, Alavian S, Esfahani A, Assari S: Seroepidemiology of hepatitis E virus in Iranian soldiers. Hep. Mon. 7, 123-126 (2007).
38. Bryan JP, Iqbal M, Tsarev S et al.: Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan. Am. J. Trop. Med. Hyg. 67, 662-668 (2002).
39. Shrestha MP, Scott RM, Joshi DM et al.: Safety and efficacy of a recombinant hepatitis E vaccine. N. Engl. J. Med. 356, 895-903 (2007).
40. Peron JM, Bureau C, Poirson H et al.: Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J. Viral Hepat. 14, 298-303 (2007).
41. Tsarev SA, Tsareva TS, Emerson SU et al.: Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc. Natl. Acad. Sci. USA 91, 10198-10202 (1994).
42. Wang L, Zhuang H: Hepatitis E: an overview and recent advances in vaccine research. World J. Gastroenterol. 10, 2157-2162 (2004).
43. Worm HC, Wirnsberger G: Hepatitis E vaccines: progress and prospects. Drugs 64, 1517-1531 (2004).
44. Purdy MA, McCaustland KA, Krawczynski K, Spelbring J, Reyes GR, Bradley DW: Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV). J. Med. Virol. 41, 90-94 (1993).
45. Im SW, Zhang JZ, Zhuang H et al.: A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 19, 3726-3732 (2001).
46. Li SW, Zhang J, Li YM et al.: A bacterially expressed particulate hepatitis E'vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23, 2893-2901 (2005).
47. Kamili S, Spelbring J, Krawcynski K: DNA vaccination against hepatitis E virus inkction in cynomolgus macaques. J. Gastroenterol Hepatol. 17(Suppl. 3), S365-S369 (2002).
48. Kamili S, Spelbring J, Carson D, Krawczynski K: Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection. J. Infect. Dis. 189, 258-264 (2004).
49. Zhou YX, Lee MY, Ng JM et al.: A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J. Gastroenterol. 12, 306-312 (2006).
50. Maloney BJ, Takeda N, Suzaki Y et al.: Challenges in creating a vaccine to prevent hepatitis E. Vaccine 23, 1870-1874 (2005).
51. Renoux VM Fleuty MJ, Bousarghin L et al.: Induction of antibody response against hepatitis E virus (HEV) whh recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine 26, 6602-6607 (2008).
52. Acharya SK, Panda SK: Hepatitis E virus: epidemiology, diagnosis, pathology and prevention. Trop. Gastroenterol. 27, 63-68 (2006).
53. Deshmukh TM, Lole KS, Tripathy AS, Arankalle VA: Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Vaccine 25, 4350-4360 (2007).
54. Dong C, Dai X, Meng JH: The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E. Vaccine 25, 1662-1668 (2007).
55. Hong Y, Ruan B, Yang LH et al.: Hepatitis E virus chimeric DNA vaccine elicits immunologic response in mice. World J. Gastroenterol. 11, 6713-6715 (2005).
56. Li F, Riddell MA, Seow HF, Takeda N, Miyamura T, Anderson DA: Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein. J. Med. Virol. 60, 379-386 (2000).
57. Li F, Torresi J, Locarnini SA et al.: Amino-terminal epitopes are exposed when full-length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy-terminal epitopes are masked. J. Med. Virol. 52, 289-300 (1997).
58. Li F, Loke P, Healy A et al.: The effect of antigen targeting sequences on antibody responses to hepatitis E virus DNA vaccines in rats and sheep. Vaccine 24, 1367-1377 (2006).
59. Li T, Takeda N, Miyamura T: Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 19, 3476-3484 (2001).
60. Li TC, Yamakawa Y, Suzuki K et al.: Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71, 7207-7213 (1997).
61. Lu F, Zhuang H, Zhu Y, Zhu X: A preliminary study on immune response to hepatitis E virus DNA vaccine in mice. Chin. Med. J. 109, 919-921 (1996).
62. Niikura M, Takamura S, Kim G et al.: Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 293, 273-280 (2002).
63. Li TC, Suzaki Y, Ami Y, Dhole TN, Miyamura T. Takeda N: Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles. Vaccine 22, 370-377 (2004).
64. Purcell RH, Nguyen H, Shapiro M et al.: Preclinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 21, 2607-2615 (2003).
65. Tsarev SA, Tsareva TS, Emerson SU et al.: Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 15, 1834-1838 (1997).
66. Zhang M, Emerson SU, Nguyen H et al.: Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques. Vaccine 20, 3285-3291 (2002).
67. Safary A: Perspectives of vaccination against hepatitis E. Intervirology 44, 162-166 (2001).
68. Stevenson P: Nepal calls the shots in hepatitis E virus vaccine trial. Lancet 355(9215), 1623 (2000).
69. Zhang JZ, Ng MH, Xia NS et al.: Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J. Med. Virol. 64, 125-132 (2001).
70. He J, Hoffman SL, Hayes CG: DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine 15, 357-362 (1997).
71. He J, Hayes CG, Binn LN et al.: Hepatitis E virus DNA vaccine elicits immunologic memory in mice. J. Biomed. Sci. 8, 223-226 (2001).
72. Tsarev SA, Tsareva TS, Emerson SU et al.: ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J. Infect. Dis. 168, 369-378 (1993).
73. Robinson RA, Burgess WH, Emerson SU et al.: Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr. Purif. 12, 75-84 (1998).
74. Schofield DJ, Glamann J, Emerson SU, Purcell RH: Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J. Virol. 74, 5548-5555 (2000).
75. Zhang M, Emerson SU, Nguyen H et al.: Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine 20, 853-857 (2001).